Evidence map›Paper›PMID 25483193›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion.

Xiao Ling Li, Xing Lu, Swetha Parvathaneni, Sven Bilke, Hongen Zhang, Saravanabhavan Thangavel, Alessandro Vindigni, Toshifumi Hara, Yuelin Zhu, Paul S Meltzer and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. RecQ Helicase Somatic Alterations in Cancer.Frontiers in molecular biosciences · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Stress Marks on the Genome: Use or Lose?International journal of molecular sciences · 2019
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Xiao Ling Lia Regulatory RNAs and Cancer Section; Genetics Branch; National Cancer Institute; National Institutes of Health; Bethesda, MD USA.
Xing Lu
Swetha Parvathaneni
Sven Bilke
Hongen Zhang
Saravanabhavan Thangavel
Alessandro Vindigni
Toshifumi Hara
Yuelin Zhu
Paul S Meltzer
Ashish Lal
Sudha Sharma
Howard University · USNational Cancer Institute · USLaboratory of Molecular Genetics · PLNational Institutes of Health · USSaint Louis University · US

Funding

Cancer Genomics Technology DevelopmentZIABC011091 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MELTZER, PAUL S. · 2009 to 2025
$16.9M
PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
Molecular Analysis of RECQ1 Functions in Genome MaintenanceSC1GM093999 · NIGMS · HOWARD UNIVERSITY · PI SHARMA, SUDHA · 2010 to 2019
$3.0M
New Mechanisms of Replication Stress ResponseR01GM108648 · NIGMS · SAINT LOUIS UNIVERSITY · PI VINDIGNI, ALESSANDRO · 2014 to 2018
$1.4M
NIGMS NIH HHS 5SC1GM093999-04NIGMS NIH HHS R01 GM108648NIGMS NIH HHS R01GM108648NIGMS NIH HHS SC1 GM093999NIMHD NIH HHS G12 MD007597NIMHD NIH HHS G12MD007597
6 · The paper itself

Abstract

The RECQ protein family of helicases has critical roles in protecting and stabilizing the genome. Three of the 5 known members of the human RecQ family are genetically linked with cancer susceptibility syndromes, but the association of the most abundant human RecQ homolog, RECQ1, with cellular transformation is yet unclear. RECQ1 is overexpressed in a variety of human cancers, indicating oncogenic functions. Here, we assessed genome-wide changes in gene expression upon knockdown of RECQ1 in HeLa and MDA-MB-231 cells. Pathway analysis suggested that RECQ1 enhances the expression of multiple genes that play key roles in cell migration, invasion, and metastasis, including EZR, ITGA2, ITGA3, ITGB4, SMAD3, and TGFBR2. Consistent with these results, silencing RECQ1 significantly reduced cell migration and invasion. In comparison to genome-wide annotated promoter regions, the promoters of genes downregulated upon RECQ1 silencing were significantly enriched for a potential G4 DNA forming sequence motif. Chromatin immunoprecipitation assays demonstrated binding of RECQ1 to the G4 motifs in the promoters of select genes downregulated upon RECQ1 silencing. In breast cancer patients, the expression of a subset of RECQ1-activated genes positively correlated with RECQ1 expression. Moreover, high RECQ1 expression was associated with poor prognosis in breast cancer. Collectively, our findings identify a novel function of RECQ1 in gene regulation and indicate that RECQ1 contributes to tumor development and progression, in part, by regulating the expression of key genes that promote cancer cell migration, invasion and metastasis.

Indexed as

Gene Expression Regulation, NeoplasticTranscriptomeCell Line, TumorCell MovementCell ProliferationDNA DamageDNA RepairGene Knockdown TechniquesHumansNeoplasm InvasivenessRecQ HelicasesRecQ HelicasesRECQL protein, humancancercell invasioncell migrationG4 DNAgene expressionhelicaseRecQtranscription

Identifiers

PMID25483193
PMCPMC4128887
OpenAlexW2096726943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.